Edge lifting observed after lamination – inspection finding risk







Published on 03/01/2026

Addressing Edge Lifting Issues in Transdermal Patch Production

Edge lifting is a notable defect observed in transdermal patches, particularly after the lamination process. This defect can pose significant risks during regulatory inspections and affect product integrity. In this article, we will provide a step-by-step guide for pharmaceutical professionals to effectively investigate and address edge lifting issues, ensuring compliance with Good Manufacturing Practices (GMP) and regulatory requirements.

By the end of this article, manufacturing and quality assurance teams will have a thorough understanding of the signals, probable causes, investigation workflows, and necessary corrective actions associated with edge lifting observed after lamination. Our structured approach ensures that your processes remain inspection-ready and capable of addressing similar issues swiftly.

Symptoms/Signals on the Floor or in the Lab

Identifying early signals of edge lifting is critical for timely intervention and mitigation of potential product failures. Symptoms may

be observed both visually and through functional testing. Here are common indicators:

  • Visual Inspection: Observing the edges of the patch lifting away from the backing material.
  • Functional Testing: Checking adhesion properties through peel tests, where deviations from expected performance may indicate potential edge lift.
  • Complaints: Receiving reports from end users related to the efficacy and adhesion of the transdermal patches.
  • Batch Review: Noticing an increased rate of out-of-spec (OOS) results in adhesion tests associated with affected batches.

Timely recognition of these signals allows teams to initiate investigations quickly to minimize impact on product quality and regulatory compliance.

Likely Causes

Understanding the potential causes of edge lifting is essential for an effective investigation. The following categories can help guide the assessment of possible root causes:

Category Likely Causes
Materials Using inappropriate backing materials, poor adhesive quality, or improper film thickness.
Method Incorrect lamination speed or temperature settings during the production process.
Machine Equipment malfunctions, wear and tear on laminating machinery, or incorrect calibration.
Man Inadequate training of operators, leading to improper handling or application processes.
Measurement Inaccurate measurement techniques affecting adhesive application or environmental testing.
Environment Improper storage conditions (temperature/humidity), leading to material degradation.

Careful analysis of these categories can assist teams in focusing their investigation effectively and can be documented for inspection readiness.

Pharma Tip:  Drug crystallization during patch manufacturing – CAPA documentation failure

Immediate Containment Actions (first 60 minutes)

Once edge lifting is detected, immediate containment is crucial to prevent further production of defective patches. The following actions should be taken within the first hour:

  1. Halt Production: Stop the production line promptly to prevent additional defects.
  2. Quarantine Affected Batches: Isolate the materials and batches suspected to exhibit edge lifting for further evaluation.
  3. Ensure Operator Awareness: Notify personnel on the floor about the defect to enhance vigilance during operations.
  4. Perform Preliminary Assessment: Conduct an initial review of the production and quality data associated with the affected batches.
  5. Document Everything: Maintain stringent documentation about the incident, including timestamps, observations, and any immediate actions taken.

By following these containment steps, you can prevent a potential escalation of the issue and safeguard product quality.

Investigation Workflow

To systematically investigate edge lifting, a structured workflow should be established:

  1. Data Collection: Gather relevant production records, batch documentation, environmental conditions, and any operator notes that may shed light on the incident.
  2. Interview Personnel: Speak with operators and quality assurance staff involved in the affected production runs to gain insights into any abnormalities observed during processing.
  3. Review Testing Results: Analyze results from adhesion, peel strength, and any OOS instances related to the batches in question.
  4. Identify Trends: Look for patterns in defect occurrences to uncover any shifts in raw materials, methods, or environmental controls.
  5. Compile a Comprehensive Report: Document findings clearly, which may prove vital for both internal assessment and demonstrating accountability to regulatory bodies.

Through diligent investigation, teams can effectively correlate findings with potential root causes of edge lifting.

Root Cause Tools (5-Why, Fishbone, Fault Tree)

Implementing effective root cause analysis (RCA) tools can lead to valuable insights into edge lifting incidents. Here are three established techniques:

5-Why Analysis

This method involves asking “Why?” repeatedly (typically five times) to drill down to the root cause of a problem. It is particularly useful for identifying underlying issues relating to human performance and procedural errors.

Fishbone Diagram (Ishikawa)

The Fishbone diagram allows teams to visually categorize potential causes into various categories (materials, methods, machines, etc.). This tool is ideal for complex issues like edge lifting, which may arise from interconnected factors.

Fault Tree Analysis

This deductive method enables the identification of various combinations of failures that could lead to edge lifting. It is beneficial for systematically analyzing machine-related or method-related failures.

Choosing the right RCA tool depends on the complexity of the investigation and the nature of the factors contributing to edge lifting.

Pharma Tip:  Drug crystallization during storage – process vs material root cause

CAPA Strategy (Correction, Corrective Action, Preventive Action)

A comprehensive Corrective and Preventive Action (CAPA) plan is necessary to address edge lifting and prevent its recurrence. Here’s how to structure the CAPA:

  1. Correction: Immediately correct any noncompliant actions identified during the investigation, such as adjusting lamination parameters or training personnel on proper procedures.
  2. Corrective Action: More long-term solutions, such as requalifying equipment showing signs of wear, or sourcing higher quality materials, should stem from root cause insights.
  3. Preventive Action: Establish robust monitoring systems for environmental conditions and material integrity to spot potential defects before they impact production.

Documentation of each step undertaken in the CAPA process is essential for compliance with regulatory standards and audit readiness.

Related Reads

Control Strategy & Monitoring

A proactive control strategy and monitoring framework are vital for sustaining operational quality and reliability in transdermal patch production:

  • Statistical Process Control (SPC): Use SPC techniques to monitor process performance and identify outliers indicative of an edge lifting issue.
  • Sampling Plans: Implement structured sampling plans for testing adhesive strength throughout production, capturing data necessary for trend analysis.
  • Alarms and Alerts: Set alarms for critical process variables (temperature, humidity, etc.) that could affect adhesion qualities.
  • Verification: Regularly verify the effectiveness of the control measures by conducting routine audits and assessments.

Engaging in these monitoring practices helps maintain a quality baseline and allows for rapid response if edge lifting or other defects are observed.

Validation / Re-qualification / Change Control Impact

Understanding the implications of edge lifting defects may necessitate further validation, re-qualification, or change control actions:

  • Validation: Any changes in materials, methods, or equipment must undergo validation to confirm their efficacy in preserving product integrity.
  • Re-qualification: If equipment changes are made following a failure, re-qualification is essential to ensure that the new setup performs reliably.
  • Change Control: Maintain a rigorous change control process to assess the impact of modifications on product quality and regulatory compliance.

These measures uphold a high standard of quality assurance while ensuring adherence to regulatory frameworks established by entities such as the FDA and the EMA.

Inspection Readiness: What Evidence to Show

To remain inspection-ready following an incident of edge lifting, teams should ensure that they can readily present the following documentation:

  • Records of Investigation: Complete records of the investigation process, including data collected, interviews conducted, and findings documented.
  • Batch Production Records: Detailed batch records that exhibit adherence to production protocols and any deviations noted.
  • OOS Reports: Investigative reports for any instances where edge lifting has resulted in out-of-specification outcomes.
  • CAPA Documentation: Comprehensive CAPA documentation reflecting corrective and preventive actions taken in response to the findings.
Pharma Tip:  Adhesion failure during patch manufacturing – process vs material root cause

Maintaining these records supports compliance inquiries and reinforces the organization’s commitment to quality.

FAQs

What is edge lifting in transdermal patches?

Edge lifting is a manufacturing defect where the edges of a transdermal patch separate from the backing material, which can compromise the product’s performance.

How can early signs of edge lifting be detected?

Early signs can be identified through visual inspections, functional tests such as peel strength assessments, and user complaints.

What immediate actions should be taken if edge lifting is observed?

Immediate actions include halting production, quarantining affected batches, and notifying relevant personnel.

Which root cause analysis tool is best for investigating edge lifting?

The choice of root cause analysis tool depends on the complexity of the issue. The Fishbone diagram is often suitable for multifaceted problems, while 5-Why is effective for straightforward inquiries.

What components comprise a CAPA plan for edge lifting?

A complete CAPA plan includes correction, corrective action, and preventive action steps to address and prevent recurrence of the defect.

How can statistical process control help manage edge lifting risks?

Statistical process control can help monitor critical process parameters and detect deviations that may lead to edge lifting before they escalate.

What documentation demonstrates inspection readiness post-investigation?

Inspection readiness documentation should include investigation records, batch production logs, OOS reports, and CAPA documentation.

Are there any regulatory guidelines to follow regarding manufacturing defects?

Yes, the FDA, EMA, and other regulatory bodies outline specific quality requirements and expectations for addressing manufacturing defects, which should be adhered to rigorously.

How often should training be conducted to prevent edge lifting?

Training should be conducted whenever there is a change in processes, materials, or following an incident, along with periodic refresher courses for operational staff.

What role does change control play in addressing edge lifting risks?

Change control ensures that any alterations made to processes or materials are assessed for impact on product quality, helping to mitigate risks such as edge lifting.

Is it necessary to validate new materials or equipment after an issue?

Yes, validating any new materials or equipment is essential to ensure their suitability for maintaining product quality and adherence to regulatory standards.